Peptide Receptor Radionuclide Therapy and Primary Brain Tumors: An Overview.

Cimini, Andrea; Ricci, Maria; Russo, Francesca; Egidi, Martina; Calabria, Ferdinando; Bagnato, Antonio; Schillaci, Orazio; Chiaravalloti, Agostino

Cimini, Andrea; Ricci, Maria; Russo, Francesca; Egidi, Martina; Calabria, Ferdinando; Bagnato, Antonio; Schillaci, Orazio; Chiaravalloti, Agostino.

Afiliação

Cimini A; Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.
Ricci M; Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.
Russo F; Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.
Egidi M; Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.
Calabria F; Department of Nuclear Medicine and Theragnostics, "Mariano Santo" Hospital, 87100 Cosenza, Italy.
Bagnato A; Department of Nuclear Medicine and Theragnostics, "Mariano Santo" Hospital, 87100 Cosenza, Italy.
Schillaci O; Department of Biomedicine and Prevention, University Tor Vergata, 00133 Rome, Italy.
Chiaravalloti A; Department of Nuclear Medicine, IRCCS Neuromed, 86077 Pozzilli, Italy.

Pharmaceuticals (Basel) ; 14(9)2021 Aug 29.

Article em En | MEDLINE | ID: mdl-34577572

Palavras-chave

nuclear medicine; peptide receptor radionuclide therapy; primary brain tumors; radiopharmaceuticals; theragnostics

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google